Sun Pharma posted a net loss of Rs 1,655.60 crore for the corresponding period of the previous fiscalSun Pharma posted a net loss of Rs 1,655.60 crore for the corresponding period of the previous fiscalDrug major Sun Pharmaceutical Industries on Friday reported a net profit of Rs 1,444.17 crore for the quarter ended June 30, 2021.
The company had posted a net loss of Rs 1,655.60 crore for the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing.
Consolidated revenue from operations stood at Rs 9,718.74 crore for the quarter under consideration. It was Rs 7,585.25 crore for the same period a year ago, it added.
Shares of Sun Pharmaceutical Industries were trading at Rs 759.10 per scrip on the BSE, up 7.94 percent from their previous close.
All IndiGo flights departing from Delhi airport cancelled till midnight, 235 flights affected
SBI, HDFC, ICICI, Kotak Bank: Likely NIM impact as RBI cuts rate by 25 basis points
RBI rate cut: Sensex rises 400 pts from day's low, Nifty crosses 26,000 mark 
Explained: Will IndiGo get a relaxation of pilot duty norms?
Apple FaceTime app blocked in Russia, government alleges 'criminal activity use'
Putin’s India Visit: Defence, Trade & Strategy On Agenda As Modi Sets Stage For Key Talks
Roscongress Foundation CEO | Russia Wants To Deepen India Trade, Ease Trade Barriers For SMEs
Modi–Putin Car Diplomacy Returns | A Warm Welcome That Signals Deep Strategic Bonds
Aruna Tummala, Business Manager At Corpus Software, Talks About Her BT Golf 25-26 Experience
IndiGo Chaos: Mass Flight Cancellations Leave Passengers Stranded At Major Airports
Suzlon shares: RE firm pays penalty amid buzz over new factories; stock reactsSBI, HDFC, ICICI, Kotak Bank: Likely NIM impact as RBI cuts rate by 25 basis points
DIIs give Rs 7 lakh crore support to stock market in 2025; what's ahead? 
Russia's Sberbank launches Nifty50-linked 'First–India' mutual fund for retail investors
Adani Ports partners with Motherson to build auto export hub at Dighi Port; stock reacts